Investigational Drug Treatments for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BC) and accounts for 10–20% of cases. Due to the lack of expression of several receptors, hormone therapy is largely ineffective for treatment purposes. Nevertheless, TNBC often responds very well to chemotherapy, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Damaskos, Christos, Garmpis, Nikolaos, Garmpi, Anna, Nikolettos, Konstantinos, Sarantis, Panagiotis, Georgakopoulou, Vasiliki E., Nonni, Afroditi, Schizas, Dimitrios, Antoniou, Efstathios A., Karamouzis, Michalis V., Nikolettos, Nikos, Kontzoglou, Konstantinos, Patsouras, Alexandros, Voutyritsa, Errika, Syllaios, Athanasios, Koustas, Evangelos, Trakas, Nikolaos, Dimitroulis, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303312/
https://www.ncbi.nlm.nih.gov/pubmed/34357119
http://dx.doi.org/10.3390/jpm11070652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303312/
https://www.ncbi.nlm.nih.gov/pubmed/34357119
http://dx.doi.org/10.3390/jpm11070652

Ejemplares similares